ELITE PHARMACEUTICALS INC /NV/
ELTPNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ELTP. That does not mean none is planned.
Get an email about ELTP's next catalysts
Track ELITE PHARMACEUTICALS INC /NV/ (ELTP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxycodone/Naltrexone Capsules | Phase 3 | Withdrawal Symptoms | - | - |
Oxycodone Naltrexone (a) | Phase 3 | Pain | - | - |
Frequently asked questions
What is in ELITE PHARMACEUTICALS INC /NV/'s drug pipeline?β
CatalystAlert tracks 2 drug candidates in ELITE PHARMACEUTICALS INC /NV/'s (ELTP) pipeline across Phase 3. Its lead program is Oxycodone Naltrexone (a) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ELITE PHARMACEUTICALS INC /NV/'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for ELITE PHARMACEUTICALS INC /NV/ (ELTP) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track ELTP biotech catalysts?β
Add ELTP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ELITE PHARMACEUTICALS INC /NV/'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
